179 related articles for article (PubMed ID: 36841865)
1. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma.
He X; Zhou Y; Chen W; Zhao X; Duan L; Zhou H; Li M; Yu Y; Zhao J; Guo Y; Gu H; Jiang Y; Dong Z; Liu K
Oncogene; 2023 Apr; 42(15):1209-1223. PubMed ID: 36841865
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern.
Xue Z; Nuerrula Y; Sitiwaerdi Y; Eli M
Biomol Biomed; 2024 May; 24(3):545-559. PubMed ID: 38340316
[TBL] [Abstract][Full Text] [Related]
3. Polygalacin D suppresses esophageal squamous cell carcinoma growth and metastasis through regulating miR-142-5p/Nrf2 axis.
Xiao S; Liu N; Yang X; Ji G; Li M
Free Radic Biol Med; 2021 Feb; 164():58-75. PubMed ID: 33307164
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.
Zhang Z; Xiong R; Li C; Xu M; Guo M
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
[TBL] [Abstract][Full Text] [Related]
6. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
[TBL] [Abstract][Full Text] [Related]
7. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
[TBL] [Abstract][Full Text] [Related]
8. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
10. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2.
Han M; Li N; Li F; Wang H; Ma L
Hum Cell; 2020 Jul; 33(3):641-651. PubMed ID: 32419118
[TBL] [Abstract][Full Text] [Related]
11. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming.
Ma Y; Zhang X; Han X; Hao Z; Ji R; Li J; Guo W; Zhang Y; Guan F; Ma S
Mol Carcinog; 2023 Jun; 62(6):866-881. PubMed ID: 36988347
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
[TBL] [Abstract][Full Text] [Related]
13. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F
Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200
[TBL] [Abstract][Full Text] [Related]
14. HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis.
Yang JY; Lei XY; He KY; Guo JR; Liu MJ; Li JQ; Li QT; Jiang ZH; Zhang L; Wu DH; Li YJ; Sun QH; Jian YP; Xu ZX
Cell Death Dis; 2024 Feb; 15(2):158. PubMed ID: 38383528
[TBL] [Abstract][Full Text] [Related]
15. Decreased Expression of NRF2 Target Genes after Alcohol Exposure in the Background Esophageal Mucosa of Patients with Esophageal Squamous Cell Carcinoma.
Toda S; Hatta W; Asanuma K; Asano N; Ono Y; Abe H; Ogata Y; Saito M; Kanno T; Jin X; Uno K; Koike T; Imatani A; Hamada S; Nakamura T; Nakaya N; Masamune A
Tohoku J Exp Med; 2022 Oct; 258(3):195-206. PubMed ID: 36070895
[TBL] [Abstract][Full Text] [Related]
16. lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.
Pan C; Chen G; Zhao X; Xu X; Liu J
Eur J Pharmacol; 2022 Nov; 934():175317. PubMed ID: 36216119
[TBL] [Abstract][Full Text] [Related]
17. NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma.
Odera JO; Xiong Z; Huang C; Gu N; Yang W; Githang'a J; Odera E; Paiboonrungruang C; Chen X
Biochem J; 2020 Aug; 477(16):3075-3089. PubMed ID: 32776152
[TBL] [Abstract][Full Text] [Related]
18. Development of targeted therapy of NRF2
Paiboonrungruang C; Simpson E; Xiong Z; Huang C; Li J; Li Y; Chen X
Cell Signal; 2021 Oct; 86():110105. PubMed ID: 34358647
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ferroptosis by noncoding RNAs: a novel promise treatment in esophageal squamous cell carcinoma.
Qiao G; Zhang W; Dong K
Mol Cell Biochem; 2022 Sep; 477(9):2193-2202. PubMed ID: 35449482
[TBL] [Abstract][Full Text] [Related]
20. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
Wang Z; Zhang J; Li M; Kong L; Yu J
Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
